Juvenile Nasopharyngeal Angiofibroma
ENT · Nose & PNS · lean revision notes
Juvenile Nasopharyngeal Angiofibroma
A benign but locally aggressive, highly vascular fibrovascular tumour that occurs almost exclusively in adolescent males. Though histologically benign, its tendency to erode bone, extend into the skull base, and bleed torrentially makes it behave clinically like a malignant lesion. JNA is a perennial NEET PG favourite for its classic demographics, the Holman-Miller sign, Sessous (Sessions) staging, and the dramatic role of pre-operative embolisation.
Definition & Key Concept
Juvenile Nasopharyngeal Angiofibroma (JNA) is the most common benign tumour of the nasopharynx. It arises from the fibrovascular stroma in the region of the sphenopalatine foramen and the pterygopalatine fossa. The lesion is composed of an irregular vascular network (thin-walled vessels lacking smooth muscle and elastic fibres → poor contractility → profuse bleeding) embedded in a fibrous stroma.
High-yield: JNA occurs almost exclusively in adolescent males (10–25 years, peak 14–17). Its occurrence in a female should prompt karyotyping to rule out a chromosomal abnormality / testicular feminisation, and it should make you reconsider the diagnosis.
Why male predominance?
The tumour is testosterone-dependent / androgen-sensitive and oestrogen-responsive (oestrogen may cause regression). This hormonal sensitivity explains the strict male, pubertal-age distribution and the historical (now largely abandoned) use of hormonal therapy.
Site of Origin
The precise origin is debated, but the most accepted site is the posterolateral wall of the nasal cavity / roof of the pterygopalatine fossa, near the sphenopalatine foramen at the junction of the sphenoid process of the palatine bone, the horizontal ala of the vomer, and the root of the pterygoid process.
High-yield: Site of origin = sphenopalatine foramen (junction of palatine bone, vomer, and pterygoid process). The tumour then spreads along natural foramina and fissures before eroding bone.
Routes of spread (think foramina → fissures → bone)
- Medially → nasal cavity and nasopharynx (commonest visible presentation).
- Laterally → pterygopalatine fossa, then through the pterygomaxillary fissure into the infratemporal fossa → cheek/temporal swelling.
- Superiorly → sphenoid sinus, then erosion into the skull base → intracranial (usually extradural) extension.
- Anteriorly → bows the posterior wall of the maxillary antrum forward (radiological antral sign).
Blood Supply
| Feature | Detail |
|---|---|
| Principal feeder | Internal maxillary artery (terminal branch of external carotid) |
| Other ECA feeders | Ascending pharyngeal artery, branches of facial artery |
| In large/intracranial tumours | Internal carotid artery contributions (e.g., via internal maxillary, ascending pharyngeal anastomoses) |
| Clinical relevance | Dual/bilateral supply explains incomplete devascularisation and recurrence after embolisation |
High-yield: Main arterial supply is the internal maxillary artery (a branch of the external carotid). Large lesions may recruit internal carotid artery branches — important during embolisation, as ICA feeders cannot be safely embolised.
Clinical Features
The classic presenting triad of an adolescent boy is the single most tested clinical fact:
Recurrent profuse unilateral epistaxis → progressive nasal obstruction → a nasopharyngeal mass.
High-yield: Classic triad = recurrent unilateral epistaxis + unilateral nasal obstruction + adolescent male. Epistaxis is typically profuse, recurrent, and spontaneous.
Symptom-by-symptom
- Epistaxis: Recurrent, profuse, often the alarming first symptom. Caused by friable thin-walled vessels.
- Nasal obstruction: Progressive, usually unilateral initially, becoming bilateral; nasal discharge and rhinolalia clausa (denasal speech).
- Cheek swelling / facial deformity: Lateral extension into the infratemporal fossa fills out the cheek; "frog face" deformity with massive lesions.
- Proptosis & diplopia: Orbital extension via the inferior orbital fissure.
- Conductive deafness / otitis media with effusion: Eustachian tube obstruction.
- Anosmia, broadening of nasal bridge.
- Headache, visual loss, cranial nerve palsies: Intracranial / cavernous sinus involvement (advanced).
Examination
- Anterior rhinoscopy / endoscopy: smooth, lobulated, pink-to-reddish mass, may bleed on touch.
- Posterior rhinoscopy: mass filling the nasopharynx.
High-yield: NEVER biopsy a suspected JNA in the OPD/clinic — torrential, life-threatening haemorrhage may follow. Diagnosis is made on imaging, not biopsy.
Diagnosis & Investigation of Choice
Diagnosis is clinico-radiological. Imaging both confirms the diagnosis and maps extent for staging and surgical planning.
Stepwise diagnostic approach
- Adolescent male + recurrent epistaxis + nasal mass → suspect JNA.
- Contrast-enhanced CT (CECT) of nose, PNS, nasopharynx, skull base → bony erosion and the diagnostic Holman-Miller sign.
- MRI with contrast → soft-tissue extent, intracranial/orbital spread, dural involvement (best for soft tissue & follow-up).
- Digital subtraction angiography (DSA) → defines feeding vessels; combined with pre-operative embolisation.
- No biopsy.
Holman-Miller sign (antral sign): Anterior bowing of the posterior wall of the maxillary sinus on lateral imaging — considered pathognomonic of JNA.
| Modality | Best for | Key finding |
|---|---|---|
| CECT | Bony detail, staging | Holman-Miller sign, intense enhancement, widening of pterygopalatine fossa |
| MRI (Gd) | Soft tissue, intracranial/orbital extent, recurrence surveillance | "Salt-and-pepper" appearance (flow voids), avid enhancement |
| DSA / angiography | Vascular mapping + treatment | Tumour blush; feeders from internal maxillary artery; allows embolisation |
High-yield: CECT is the investigation of choice for diagnosis and shows the Holman-Miller sign; MRI best delineates intracranial/orbital soft-tissue extent and is preferred for post-operative follow-up to detect recurrence.
Histopathology
- Two components: vascular + fibrous (hence angio-fibroma).
- Vessels: thin-walled, lack a complete muscular coat and elastic lamina → cannot constrict → profuse bleeding when traumatised.
- Stroma: abundant fibrous tissue with stellate/spindle fibroblasts; mast cells present.
- Stains: lesion is androgen-receptor positive.
- Behaviour: histologically benign; no metastasis; locally invasive.
Staging — Sessous (Sessions) / Fisch / Radkowski / Andrews
Several systems exist; Sessous (Sessions) and Fisch are the most quoted, with Radkowski being a Sessions modification.
Sessions (Sessous) staging
| Stage | Extent |
|---|---|
| I | Limited to nasopharynx / nasal cavity, no bony erosion |
| II | Extension into PNS (maxillary, ethmoid, sphenoid) with bony destruction |
| III | Extension into infratemporal fossa or orbit |
| IV | Intracranial extension |
Fisch staging (commonly tested)
| Stage | Extent |
|---|---|
| I | Confined to nose & nasopharynx, no bony destruction |
| II | Invades pterygopalatine fossa, maxillary/ethmoid/sphenoid sinus with bony destruction |
| III | Invades infratemporal fossa, orbit, parasellar region remaining lateral to cavernous sinus |
| IV | Invades cavernous sinus, optic chiasm region, pituitary fossa |
High-yield: Remember that Stage I = no bony erosion, and the jump to intracranial extension marks the highest stage. Radkowski staging is a modification of the Sessions system widely used by ENT surgeons.
Management & Treatment of Choice
High-yield: Surgical excision is the treatment of choice. It is typically preceded by angiographic embolisation 24–48 hours pre-operatively to reduce intra-operative bleeding.
Pre-operative embolisation
- Performed 24–48 hours before surgery (optimal window — earlier risks recanalisation/collaterals).
- Embolises external carotid (internal maxillary) feeders.
- Internal carotid feeders cannot be embolised safely (risk of stroke) — a limitation in large tumours.
- Reduces blood loss and improves surgical field.
Surgical approaches (selected by stage/extent)
- Endoscopic endonasal resection — preferred for early-stage (I–II) disease today; less morbidity, no external scar.
- Transpalatal approach — for tumours limited to nasopharynx/nasal cavity.
- Lateral rhinotomy / Weber-Ferguson incision — for wider access.
- Mid-facial degloving — avoids facial scar.
- Infratemporal fossa approach (Fisch) — for large lesions with ITF/lateral skull base extension.
- Le Fort I osteotomy — provides wide access for extensive lesions.
- Craniofacial resection — for intracranial extension.
Adjuvant / alternative options
- Radiotherapy: reserved for intracranial extension, unresectable disease, or recurrence. Disadvantage in adolescents — risk of growth retardation, optic neuropathy, and radiation-induced malignancy later.
- Hormonal therapy (oestrogens / flutamide): largely historical; may shrink tumour but side effects (feminisation) limit use.
- Spontaneous regression: reported after the age of ~25 years (post-pubertal involution).
High-yield: Stepwise plan → CECT/MRI diagnosis → DSA + embolisation (24–48 h prior) → surgical excision (endoscopic for early stage; open/skull-base approaches for advanced). Radiotherapy is reserved for intracranial / unresectable / recurrent disease.
Complications
Of the disease
- Massive, recurrent epistaxis → anaemia, hypovolaemic shock.
- Bony erosion of skull base, orbit → proptosis, visual loss, cranial nerve palsies.
- Intracranial / cavernous sinus extension.
- Facial deformity ("frog face"), nasal bridge widening.
Of treatment
- Catastrophic intra-operative haemorrhage (mitigated by embolisation).
- Recurrence — common with incomplete excision, dual blood supply, or intracranial residual; reported in 20–40% depending on stage.
- Embolisation hazards: stroke/blindness if ICA territory inadvertently embolised; skin/mucosal necrosis.
- Radiotherapy: growth retardation, osteoradionecrosis, secondary malignancy, cataract, optic neuropathy.
High-yield: Recurrence is most strongly associated with incomplete removal and intracranial extension / residual at the skull base; MRI is used for surveillance.
Key Differential Diagnoses
| Condition | Distinguishing point |
|---|---|
| Antrochoanal polyp | Arises from maxillary antrum; pale, non-vascular; can occur in children; does not bleed; trilobed (antrum-choana-nasopharynx) |
| Nasopharyngeal carcinoma | Older age, neck nodes (often presenting), EBV association, biopsy-confirmed |
| Rhabdomyosarcoma | Young children; rapidly growing malignant mass |
| Chordoma | Midline clival mass; bony destruction |
| Nasal/nasopharyngeal lymphoma | Systemic features; biopsy |
| Encephalocoele / meningocoele | Cribriform plate defect; do not biopsy a "nasal polyp" in an infant without imaging — pulsatile, CSF leak risk |
| Haemangioma / bleeding polyp of septum | Anterior septal location; small; in adults/pregnancy |
High-yield: A pale, non-bleeding nasal mass in a child = think antrochoanal polyp; a vascular, bleeding nasal mass in an adolescent boy = think JNA. Never confuse the two — biopsy is safe for the former, dangerous for the latter.
Mnemonics & Eponyms
- "JNA — Just Never biopsy in the clinic / Adolescent male."
- Triad mnemonic — "BON": Bleeding (epistaxis), Obstruction (nasal), Nasopharyngeal mass.
- Holman-Miller (antral) sign — anterior bowing of posterior maxillary wall (pathognomonic).
- Fisch / Sessions / Radkowski / Andrews — the four staging eponyms (Radkowski = modified Sessions).
- Internal Maxillary artery = main feeder → "IMA the main supplier."
Recently asked / exam angle
- Single best answer on demographics: "Recurrent epistaxis in an adolescent boy" → answer is JNA in almost every MCQ stem.
- Investigation of choice / sign: Holman-Miller (antral) sign on CT is repeatedly asked; CECT diagnostic, MRI for soft-tissue/follow-up.
- Blood supply: Internal maxillary artery (branch of external carotid) is a classic one-liner; large tumours recruit ICA.
- Treatment timing: Pre-operative embolisation 24–48 hours before surgery — frequently tested numerical fact.
- "Which is contraindicated?" → Biopsy of the lesion (risk of torrential bleed).
- Site of origin: Sphenopalatine foramen / posterolateral nasal wall — appears in anatomy-linked stems.
- Hormone dependence: Androgen/testosterone-sensitive; female presentation → karyotyping.
- Staging: Stage that defines bony erosion (II) vs intracranial spread (IV); matching-type questions on Fisch vs Sessions.
- Radiotherapy indication: Reserved for intracranial/unresectable/recurrent disease — assertion-reason style.
- Image-based NEET PG questions: axial CECT showing an intensely enhancing nasopharyngeal mass widening the pterygopalatine fossa with anterior maxillary wall bowing.
Rapid revision
- JNA = most common benign tumour of the nasopharynx, exclusively in adolescent males (10–25 yr).
- Origin = sphenopalatine foramen / posterolateral nasal wall; it is testosterone-sensitive.
- Classic triad = recurrent unilateral epistaxis + nasal obstruction + nasopharyngeal mass.
- Never biopsy — risk of life-threatening haemorrhage; diagnosis is radiological.
- Holman-Miller (antral) sign = anterior bowing of posterior maxillary wall = pathognomonic on CT.
- Investigation of choice = CECT; MRI best for intracranial/orbital extent and follow-up; DSA for vascular mapping.
- Main blood supply = internal maxillary artery (branch of external carotid); large tumours recruit ICA.
- Treatment of choice = surgical excision preceded by embolisation 24–48 h pre-op.
- Endoscopic excision for early stage; open/skull-base (Fisch, Le Fort I, craniofacial) approaches for advanced disease.
- Radiotherapy reserved for intracranial / unresectable / recurrent disease.
- Recurrence linked to incomplete excision and intracranial residual.
- Histology = thin-walled vessels lacking muscle/elastic coat in fibrous stroma → why it bleeds; benign, no metastasis.